In agreement with MYC-independent mechanisms of BET inhibition that take place in some tumor contexts, ectopic overexpression of MYC/MYCN is not able to abrogate the suppressive activity of BETi in neuroblastoma [26] and glioblastoma lines [41]. The gene discussed is MYCN; the disease is glioblastoma.